Imvax, Inc.

HueDx, based in Philadelphia, is revolutionizing the diagnostic process to enhance results for patients and healthcare providers. Through their innovative approach, HueDx aims to optimize outcomes and streamline the diagnostic experience for all involved. Generated from their website's infomation

Recombination Therapeutics, LLC, based in Philadelphia, PA, is a precision oncology company dedicated to eliminating cancer by targeting DNA Damage Response (DDR) factors to combat drug resistance in genetically defined patient populations. Their innovative approach focuses on DNA polymerase Theta (Polq), a crucial repair factor that is essential for the survival of homologous recombination-deficient cancer cells while being dispensable for normal cells, making it an ideal therapeutic target. The company is currently advancing its drug candidate targeting Polq in vivo and is also developing a first-in-class small-molecule inhibitor aimed at overcoming resistance to PARP inhibitors in both homologous recombination-deficient and proficient cancer cells. With a team of experienced professionals, Recombination Therapeutics is poised to make significant contributions to the field of precision oncology. Generated from the website

Our mission at Thermo Fisher is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity.